Antithrombotic therapy after infrainguinal bypass

Journal of Vascular Surgery

Volumn 60, Issue 5, 2014, Pages 1367-1375

  Maufus, Mario ^a   Pernod, Gilles ^a,b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; WARFARIN; FIBRINOLYTIC AGENT;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BYPASS SURGERY; CARDIOVASCULAR MORTALITY; CLINICAL TRIAL (TOPIC); CONSENSUS; CONTROLLED CLINICAL TRIAL (TOPIC); CRITICAL LIMB ISCHEMIA; DRUG EFFICACY; DRUG SAFETY; FEMOROPOPLITEAL BYPASS; GRAFT OCCLUSION; GRAFT PATENCY; HEALTH CARE QUALITY; HUMAN; INFRAINGUINAL BYPASS; LIMB SALVAGE; LONG TERM CARE; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SURVIVAL RATE; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); VEIN BYPASS; BLOOD VESSEL TRANSPLANTATION; CHEMICALLY INDUCED; CRITICAL ILLNESS; DRUG EFFECTS; GRAFT OCCLUSION, VASCULAR; ISCHEMIA; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; POSTOPERATIVE HEMORRHAGE; RISK; TRANSPLANTATION; TREATMENT OUTCOME; VASCULAR PATENCY; VEIN;

ADMINISTRATION, ORAL; BLOOD VESSEL PROSTHESIS IMPLANTATION; CRITICAL ILLNESS; FIBRINOLYTIC AGENTS; GRAFT OCCLUSION, VASCULAR; HUMANS; ISCHEMIA; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; RISK FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY; VEINS;

EID: 84924533864     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2014.07.105     Document Type: Review

References (19)

1. Rooke TW, Hirsch AT,Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al; American College of Cardiology Foundation; American Heart Association; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society for Vascular Medicine; Society for Vascular Surgery. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. Catheter Cardiovasc Interv 2012;79:501-31
2. Second European Consensus Document on chronic critical leg ischemia. Eur J Vasc Surg 1992;6(Suppl A):1-32
3. McPhee JT, Barshes NR, Ozaki CK, Nguyen LL, Belkin M. Optimal conduit choice in the absence of single-segment great saphenous vein for below-knee popliteal bypass. J Vasc Surg 2012;55:1008-14
4. Johnson WC, Lee KK. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous autologous vein bypass grafts for femoral-popliteal above-knee revascularization: A prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 2000;32:268-77
5. Mills JL. Mechanisms of vein graft failure: The location, distribution, and characteristics of lesions that predispose to graft failure. Semin Vasc Surg 1993;6:78-91
6. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy-II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ 1994;308:159-68
7. Brown J, Lethaby A, Maxwell H, Wawrzyniak AJ, Prins MH. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database Syst Rev 2008;(4):CD000535
8. Schneider E, Brunner U, Bollinger A. Medical treatment for preventing recurrence after femoro-popliteal arterial reconstruction. Angio 1979; 2:73-7
9. Sarac TP, Huber TS, Back MR, Ozaki CK, Carlton LM, Flynn TC, et al. Warfarin improves the outcome of infrainguinal autologous vein bypass grafting at high risk for failure. J Vasc Surg 1998;28:446-57
10. The Dutch Bypass Oral Anticoagulants or Aspirin Study Group. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery: A randomized trial. Lancet 2000;355:346-51
11. Johnson WC, Williford WO; Department of Veterans Affairs Cooperative Study #362. Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: A prospective randomized study. J Vasc Surg 2002;35:413-21
12. Jackson MR, Johnson WC, Williford WO, Valentine RJ, Clagett GP. The effect of anticoagulation therapy and graft selection on the ischemic consequences of femoropopliteal bypass graft occlusion: Results from a multicenter randomized clinical trial. J Vasc Surg 2002;35:292-8
13. Belch JJ, Dormandy J; CASPAR Writing Committee. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg 2010;52:825-33
14. Monaco M, Di Tommaso L, Pinna GB, Lillo S, Schiavone V, Stassano P. Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients. J Vasc Surg 2012;56:96-105
15. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet JP, et al. ESC Committee for Practice Guidelines. ESC guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2851-906
16. Geraghty AJ, Welch K. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery (review). Cochrane Database Syst Rev 2011;(6):CD000536
17. Alonso-Coello P, Bellmunt S, McGorrian C, Anand SS, Guzman R, Criqui MH, et al; American College of Chest Physicians. Antithrombotic therapy in peripheral artery disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012;141(2 Suppl):e669S-90S
18. ANSM (L'Agence nationale de sécurité du médicament et des produits de santé)/HAS (Haute autorité de santé). Recommandations de Bonne Pratique: Bon usage des agents antiplaquettaires. Available at: http://ansm.sante.fr/var/ansm-site/storage/original/application/e7 a6fa9454e762c375beb2567332a903.pdf. Accessed Februray 28, 2014
19. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al; for the WarfarineAspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352: 1305-16.